Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
QuintilesIMS
Queensland Health
Chubb
McKinsey
Cerilliant
Cipla
Harvard Business School
Healthtrust

Generated: April 21, 2018

DrugPatentWatch Database Preview

MIDAMOR Drug Profile

« Back to Dashboard

When do Midamor patents expire, and what generic alternatives are available?

Midamor is a drug marketed by Paddock Llc and is included in one NDA.

The generic ingredient in MIDAMOR is amiloride hydrochloride. There are five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride profile page.
Drug patent expirations by year for MIDAMOR
Pharmacology for MIDAMOR
Medical Subject Heading (MeSH) Categories for MIDAMOR
Synonyms for MIDAMOR
(3,5-diamino-6-chloropyrazin-2-yl)-N-(???methyl)carboxamide
(3,5-Diamino-6-chloropyrazinoyl)guanidine
117188-EP2277879A1
117188-EP2298776A1
137053-86-2
17440-83-4 (hydrochloride)
1f5l
2016-88-8 (anhydrous hydrochloride)
2609-46-3
3,5-diamino-6-chloro-N-(diaminomethylene)pyrazinamide;hydrochloride
3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide
3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide
3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide
3,5-diamino-N-carbamimidoyl-6-chloro-pyrazine-2-carboxamide
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
609A463
7DZO8EB0Z3
AB00053415
AB00053415_26
AB00053415_27
AB00053415_28
AB00053415-24
AB00053415-25
AC-13631
AC1L27IZ
AC1Q3POC
ACT05635
ACT05652
AKOS015961348
Amiclaran
Amiclaran (TN)
Amikal (Hydrochloride dihydrate)
Amilorid
Amilorida
Amilorida [INN-Spanish]
AMILORIDE
Amiloride (INN)
Amiloride (Na-Ca chanel blocker)
AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8))
Amiloride [INN:BAN]
Amiloride HCL
Amiloride hydrochloride hydrate
Amiloride Hydrocholride
Amiloridum
Amiloridum [INN-Latin]
Amipramidin
AMIPRAMIDINE
Amipramizid
Amipramizide
Amiprazidine
Amyloride
API0000380
BBL028157
BCBcMAP01_000101
BDBM16173
BIDD:GT0466
Biduret (TN)
Bio1_000359
Bio1_000848
Bio1_001337
Bio2_000292
Bio2_000772
BPBio1_000015
BRD-K97181089-003-02-3
BRD-K97181089-310-03-0
BSPBio_000013
BSPBio_001572
BSPBio_001826
C06821
C6H8ClN7O
CAS-2609-46-3
CCG-204206
CCRIS 6545
CHEBI:2639
CHEMBL945
CS-2297
D07447
D0I0RJ
DB00594
DivK1c_000182
DSSTox_CID_23853
DSSTox_GSID_43853
DSSTox_RID_80077
DTXSID9043853
EINECS 220-024-7
EN300-149459
F2173-0531
FT-0703177
GTPL2421
Guanamprazin
Guanamprazine
HMS1791O14
HMS1989O14
HMS2089H05
HMS2213E05
HMS3355K04
HY-B0285
IDI1_000182
IDI1_034042
J-016249
KBio1_000182
KBio2_000292
KBio2_000394
KBio2_002860
KBio2_002962
KBio2_005428
KBio2_005530
KBio3_000583
KBio3_000584
KBio3_001326
KBioGR_000292
KBioGR_000544
KBioSS_000292
KBioSS_000394
Lopac-A-7410
Lopac0_000111
LS-1094
MCULE-5948863568
Midamor (Hydrochloride dihydrate)
MK-870 (Hydrochloride dihydrate)
MLS001060798
MolPort-005-934-472
N-amidino 3,5-diamino-6-chloro-2-pyrazinecarboxamide
N-amidino-3,5-diamino-6-chloro-2-pyrazinecarboxamide
N-amidino-3,5-diamino-6-chloropyrazinamide
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid
NCGC00015089-01
NCGC00015089-02
NCGC00015089-03
NCGC00015089-04
NCGC00015089-05
NCGC00015089-06
NCGC00015089-07
NCGC00015089-08
NCGC00015089-09
NCGC00015089-11
NCGC00015089-12
NCGC00015089-13
NCGC00015089-14
NCGC00015089-15
NCGC00015089-16
NCGC00015089-17
NCGC00024443-02
NCGC00024443-05
NCGC00024443-06
NCGC00024443-07
NCGC00024443-09
NINDS_000182
Prestwick0_000007
Prestwick1_000007
Prestwick2_000007
Prestwick3_000007
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride
SBB037856
SBI-0050099.P004
SCHEMBL27562
SMR000486264
SPBio_000136
SPBio_001934
Spectrum_000034
Spectrum2_000118
Spectrum3_000293
Spectrum4_000132
Spectrum5_000776
ST079279
STL373007
Tocris-0890
Tox21_110080
Tox21_110080_1
U460
UNII-7DZO8EB0Z3
XSDQTOBWRPYKKA-UHFFFAOYSA-N
ZINC4340269

US Patents and Regulatory Information for MIDAMOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc MIDAMOR amiloride hydrochloride TABLET;ORAL 018200-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Chubb
Teva
Fuji
US Department of Justice
Queensland Health
Accenture
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.